1. Home
  2. FET vs OCS Comparison

FET vs OCS Comparison

Compare FET & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forum Energy Technologies Inc.

FET

Forum Energy Technologies Inc.

N/A

Current Price

$82.30

Market Cap

850.2M

Sector

Industrials

ML Signal

N/A

Logo Oculis Holding AG Ordinary shares

OCS

Oculis Holding AG Ordinary shares

N/A

Current Price

$8.76

Market Cap

732.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FET
OCS
Founded
2005
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
850.2M
732.4M
IPO Year
2007
2022

Fundamental Metrics

Financial Performance
Metric
FET
OCS
Price
$82.30
$8.76
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
★ $36.37
AVG Volume (30 Days)
135.0K
★ 183.9K
Earning Date
10-29-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 92.64
N/A
EPS
★ 0.39
N/A
Revenue
★ $791,474,000.00
N/A
Revenue This Year
$12.04
N/A
Revenue Next Year
$5.92
$365.20
P/E Ratio
$206.21
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$25.25
$9.00
52 Week High
$87.42
$34.48

Technical Indicators

Market Signals
Indicator
FET
OCS
Relative Strength Index (RSI) 52.01 28.67
Support Level $77.71 N/A
Resistance Level $84.18 $10.84
Average True Range (ATR) 2.75 0.49
MACD -0.59 -0.06
Stochastic Oscillator 33.91 9.78

Price Performance

Historical Comparison
FET
OCS

About FET Forum Energy Technologies Inc.

Forum Energy Technologies Inc is a manufacturing company serving the oil, natural gas, industrial, and renewable energy industries. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. The company operates in two reportable segments: Drilling and Completions, and Artificial Lift and Downhole. Maximum revenue is generated from the Drilling and Completions segment, which offers products used in the drilling process, and other products like hydraulic fracturing pumps, ROVs and trenchers, submarine rescue vehicles, etc. Geographically, the firm generates maximum revenue from the U.S., followed by Canada, Middle East, Europe and Africa, Asia-Pacific, and Latin America.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Share on Social Networks: